Location: Home
  • search
  • go
  • Relate News
  • 5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement
  • 5/24/2022ImaginAb and Yantai DongCheng Enter License Deal to Commercialize CD8...
  • 5/24/2022CASI and Tianshi Enter Sublicense Deal for Anti-Cd38 mAb CID-103 in Au...
  • 5/23/2022CDE Issues the Generic Format and Writing Guidelines for Package Inser...
  • 5/23/2022CDE Issues the Technical Guidelines for Clinical Evaluation of Intrave...
  • 5/23/2022Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...
  • 5/23/2022Novartis's Promacta Approved in China for Expanded Use in Children Ag...
  • 5/23/2022Sinohealth: Chinese Hospital Drug Sales Fell 4% in Q1/2022
  • 5/23/2022IQVIA: Chinese Hospital Drug Market Rose 4.2% in Q1/2021
  • 5/23/2022VerImmune and Fosun Pharma Enter Licensing Deal for Virus-inspired Pa...
  • 5/23/2022Biopharma in China: The Emerging Global Force of Domestic Suppliers
  • 5/20/2022U.S., European Firms Rethink China Investment After Lockdowns
  • 5/20/2022VerImmune and Fosun in Deal for VerImmune's ViP Platform as Novel Im...
  • 5/20/2022Couple Plead Guilty to Smuggling and Fraud Charges After Sending ‘mRN...
  • 5/20/2022Recent Executive Moves
  • 5/20/2022Drug R&D and Product Registration News Digest May 2022 (3)
  • 5/19/2022Chinese Courts Handled Over 640,000 IPR Cases in 2021
  • 5/19/2022China Approves Bayer/MSD's Verquvo (vericiguat) for Chronic Heart Fail...
  • 5/19/2022CTTQ and Symphogen Enter Pact for Global Rights of Latter's mAb Sym022
  • 5/19/2022CDE Issues the List of Reference Formulations for GQCE Studies (54th B...
  • 5/19/2022WHO Validates 3rd Chinese COVID-19 Vaccine for Emergency Use
  • 5/19/2022APAC Hospital Priorities 2022: Strategic Implications for Pharma Compa...
  • 5/19/2022As Losses Narrow, Is Zai Lab Finally Finding its Winning Formula?
  • 5/19/2022Pediatric Drug Development A New Investment Area in China (PharmaDJ's ...
  • 5/18/2022'Startup Like No Other': China's Hengrui launches Luzsana with Big Pha...
  • 5/17/2022Upcoming Event: 6th International Conference on Emerging Infectious Di...
  • 5/17/2022SMEI: Chinese Public Medical Institution Drug Sales Surged 7.2% in 202...
  • 5/17/2022CDE Issues the Guidelines for Evaluation of Immune-Related Adverse Eve...
  • 5/17/2022NHSA Completes Building of Unified National BMI Information Platform
  • 5/17/2022433 Listed Chinese Pharma Companies Report Their Annual Performance in...
  • Page:140/775 Total number of articles:23243: [First][<<] [138] [139] [140] [141] [142] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group